Wikidata

(Q34759197)

English

Potential benefits of the irreversible pan-erbB inhibitor, CI-1033, in the treatment of breast cancer

scientific article

In more languages

Statements

title
Potential benefits of the irreversible pan-erbB inhibitor, CI-1033, in the treatment of breast cancer (English)
1 reference
stated in
Europe PubMed Central
PubMed ID
12138393
retrieved
4 August 2017
author name string
Lee F Allen
series ordinal
1
1 reference
stated in
Europe PubMed Central
PubMed ID
12138393
retrieved
4 August 2017
Peter F Lenehan
series ordinal
2
1 reference
stated in
Europe PubMed Central
PubMed ID
12138393
retrieved
4 August 2017
Irene A Eiseman
series ordinal
3
1 reference
stated in
Europe PubMed Central
PubMed ID
12138393
retrieved
4 August 2017
William L Elliott
series ordinal
4
1 reference
stated in
Europe PubMed Central
PubMed ID
12138393
retrieved
4 August 2017
David W Fry
series ordinal
5
1 reference
stated in
Europe PubMed Central
PubMed ID
12138393
retrieved
4 August 2017
issue
3 Suppl 11
1 reference
stated in
Europe PubMed Central
PubMed ID
12138393
retrieved
4 August 2017

Identifiers

 
edit
    edit
      edit
        edit
          edit
            edit
              edit
                edit
                  edit
                    Retrieved from "https://www.wikidata.org/w/index.php?title=Q34759197&oldid=1561313386"